GC Biopharma Archives

Browsing: GC Biopharma

GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI)

Health December 18, 2023

YOGIN, South Korea, Dec. 17, 2023 /PRNewswire/ — GC Biopharma Corp (006280.KS) today announces that the US Food and Drug Administration (FDA)…

Health December 6, 2023

To commence operation by 2027…with max. 400K liters of plasma production capacity per annum The first step towards localization of…

Health October 11, 2023

YONGIN, South Korea, Oct. 10, 2023 /PRNewswire/ — GC Biopharma Corp. announced today that it has presented the successful adoption of…

Health August 30, 2023

With the participation of all affiliated group entities YONGIN, South Korea, Aug. 30, 2023 /PRNewswire/ –All executives and employees of…

Wealth February 28, 2023

Entered into an acquisition deal of 3 programs YONGIN, South Korea, Feb. 27, 2023 /PRNewswire/ — GC Biopharma Corp. (006280.KS),…

Health February 20, 2023

YONGIN, South Korea, Feb. 19, 2023 /PRNewswire/ — GC Biopharma (006280.KS), a leading provider of biopharmaceutical products in South Korea,…